3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with bremazocine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gioannini, TL; Hiller, JM; Liu, YF; Ofri, D; Ritter, AM; Simon, EJ | 1 |
| Bowen, WD; Copeland, CF; Kooper, GN; Levinson, NR | 1 |
2 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and bremazocine
| Article | Year |
|---|---|
Characterization of solubilized opioid receptors: reconstitution and uncoupling of guanine nucleotide-sensitive agonist binding.
Topics: Animals; Benzomorphans; Binding Sites; Binding, Competitive; Cattle; Cholic Acids; Corpus Striatum; Detergents; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Receptors, Opioid; Solubility | 1992 |
Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
Topics: Affinity Labels; Animals; Benzomorphans; Binding Sites; Cholic Acids; Cyclazocine; Ethylketocyclazocine; Etorphine; In Vitro Techniques; Light; Male; Narcotics; Rats; Rats, Inbred Strains; Receptors, Opioid; Tritium | 1988 |